$CLSH CLS Holdings Announces Record First Quarter Fiscal

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
47
$CLSH CLS Holdings Announces Record First Quarter Fiscal 2020 Results
Canada NewsWire


LAS VEGAS, Oct. 15, 2019 /CNW/ - CLS Holdings USA, Inc. (OTCQB: CLSH, CSE: CLSH.CN) ("CLS" or the ''Company'' , a diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce financial results for the first quarter ended August 31, 2019.

"First quarter results represent the beginning of what we expect to be a historic year for our company," commented Andrew Glashow, President and COO of CLS Holdings. "These results continue to support and validate our strategy in Nevada, including at our Oasis Cannabis dispensary and within our City Trees line of branded products. Despite the number of records established during Q1 2020, we believe our operations have room to grow and we are excited about the opportunities going forward."

Q1 2020 Highlights

Record consolidated revenue of $2.9 million compared to $1.7 million in fiscal Q1 2019, an increase of $1.2 million or 72.7%.
Record consolidated gross profit of $1.4 million, a 147.7% increase over the same period a year earlier.
Record consolidated gross profit margin of 50.6% compared to 35.3% in fiscal Q1 2019.
Consolidated net loss of $1.4 million or $0.01 per share compared to a net loss of $16.7 million or $0.23 per share in fiscal Q1 2019.
Cash and cash equivalents of $5.9 million as of August 31, 2019.
Record revenue from the Company's Oasis Cannabis dispensary of $2.1 million, a 96.6% increase over fiscal Q1 2019 revenue of $1.1 million.
Record Oasis Cannabis gross profit margin of 48.3% compared to 35.9% in fiscal Q1 2019.
A 98.4% increase in dispensary customers, from 26,438 (294 average per day) in fiscal Q1 2019 to a record 52,448 (583 average per day) in fiscal Q1 2020.
Record revenue per SF of $397 compared to $205 per SF during the same period a year earlier, an increase of 93.6%.
Record revenue from the Company's City Trees' branded products division of $0.8 million compared to $0.6 million in fiscal Q1 2019, an increase of $0.2 million or 33.6%.
Record City Trees branded products gross profit margin of 56.2% compared to 34.1% in fiscal Q1 2019.
Subsequent Second Quarter Events

In Good Health, a licensed medical dispensary, which the Company has the exclusive right to acquire in January 2020, was granted on September 13, 2019 a final license for recreational use at its current location in Brockton, MA.
Oasis Cannabis dispensary expansion expected to be completed in mid-November, increasing available retail space from 1,750 sf to 2,000 sf.
"We are incredibly pleased with our first quarter 2020 result," commented Mr. Jeffrey Binder, Chairman and Chief Executive Officer of CLS Holdings. "To this end, we reported year over year quarterly revenue growth of 72.7%. We also dramatically increased gross margins from 35.3% in Q1 2019 to 50.6% in Q1 2020, in large part due to the implementation of new processes, the retention of additional skilled employees, and an improvement in inventory purchasing. As a result, I am proud to report that our Oasis Cannabis and City Trees subsidiaries are profitable on a stand-alone basis while our consolidated net loss stems primarily from those costs associated with being a publicly traded company and costs associated with the parent holding company."

About CLS Holdings USA, Inc.
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for ''Cannabis Life Sciences,'' in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
http://www.clsholdingsinc.com
Twitter: @CLSHusa

About Oasis Cannabis
Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named ''Best Dispensary for Pot Pros'' by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products.
http://oasiscannabis.com

About City Trees
Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees is one the fastest growing wholesale companies in the industry. Its products are now available at 44 dispensaries.
https://citytrees.com

Disclaimer – Fiscal Q1 2019 Results of Operations

The Company acquired Oasis Cannabis and City Trees effective July 1, 2018. In order to provide comparable three- month quarterly periods for 2019 and 2018, the results of operations for the three months ended August 31, 2019 set forth herein include the results of the Oasis Cannabis dispensary and City Trees for the month of June 2018, when they were owned and operated by their former owners. The inclusion of this information should not be construed as an indication that the Company owned these entities during June 2018 but is only provided to assist readers in comparing current operating results with the prior operating results of these businesses.

Forward Looking Statements
This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements'' . These statements relate to anticipated future events, future results of operations or future financial performance, and anticipated growth, including the timing of anticipated construction and implementation of our expansion plan. In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance and we cannot guaranty that the proposed transactions described in this press release will occur. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.

SOURCE CLS Holdings USA Inc

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI and Workforce Transformation: Zellis Connect 2026

Updated Category News Views 2

AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 4

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 0

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 3

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
BYD's Chip Mastery Amid China's Auto Supply Tensions

Updated Category News Views 7

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

Continue Reading
PBC 2026 Forum: Philanthropic Titans Collide in HK

Updated Category News Views 0

A Decade of Philanthropic Discourse The winds of change blew through Hong Kong’s West Kowloon Cultural District today, marking the tenth anniversary of the PBC 2026 forum—an event that’s got everyone from government bigwigs to sports icons chatting. Convened by The Hong Kong Jockey Club Charities Trust alongside the Institute of Philanthropy, this two-day journey is...

Continue Reading
SKF's Automotive Arm Set for Stockholm Debut in Dec

Updated Category News Views 0

The Big Spin-Off Play: SKF Vertevo So, SKF is at it again, pushing their Automotive business out the door as a newly minted public company—SKF Vertevo—on the horizon. It's like watching a mother bird kick the fledgling out of the nest. The Board's cooked up this spin-off strategy, and they're eyeing the Nasdaq Stockholm as the breeding ground, with the gears all set...

Continue Reading
La Compagnie Unveils NYC-Düsseldorf Flight Plans

Updated Category News Views 2

A new chapter is unfolding in the skies over the Atlantic. La Compagnie is gearing up to connect New York to Düsseldorf with a direct, all-business-class flight starting in Spring 2027. This move is ambitious, tapping into the bustling economic energy present across the North Rhine-Westphalia region—an economic powerhouse littered with U.S.-affiliated businesses. A...

Continue Reading
Lyon Biennale 2026: Art, Dreams, and Lyon's Magic

Updated Category News Views 0

Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...

Continue Reading

Top 5 Most Recently Viewed Articles

HFCL's Eka™ Fiber Revolutionizes Telecom Connectivity in Europe

Updated Category News Views 150

HFCL Launches Eka™ Fiber at the FTTH Conference 2025 HFCL Limited, a global pioneer in next-generation telecommunications solutions, has unveiled its innovative Eka™ Optical Fiber at the FTTH Conference 2025. Designed in collaboration with European telecom companies, this groundbreaking fiber aims to bridge the connectivity gaps within rural and urban landscapes of...

Continue Reading
CAI Software Expands Its Manufacturing Throne with PlanetTogether

Updated Category News Views 7

CAI Software's Ambitious Move Who would've guessed, folks? Just another day in the volatile tech landscape, and we see CAI Software splashing the cash to snag PlanetTogether. This isn't just a move to puff up their chest; it's a strategic addition, placing some real weight behind their manufacturing software game. New Horizons with Advanced Planning and Scheduling...

Continue Reading
Artera Expands Its Prostate Test Availability with New License

Updated Category News Views 62

Artera Gains California Lab License to Offer Prostate Test Artera, a leader in artificial intelligence (AI) for cancer diagnostics, recently announced the attainment of its official laboratory license from the California Department of Public Health (CDPH). This important step opens the door for Artera to provide its revolutionary ArteraAI Prostate Test across one of the...

Continue Reading
Bicara Therapeutics Achieves Breakthrough Therapy Milestone for Cancer Treatment

Updated Category News Views 121

Bicara Therapeutics Updates on Financial Results and Business Strategy Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, reports its financial outcomes for the third quarter of 2025 alongside strategic business insights. One of the most noteworthy achievements this quarter is the FDA granting Breakthrough Therapy Designation for...

Continue Reading
ScanTech AI Takes Significant Step with Quarterly Filing Update

Updated Category News Views 179

ScanTech AI's Quarterly Report Filing Details ScanTech AI Systems Inc. is pleased to announce that it has successfully filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (SEC). This filing is a vital step for the company as it aligns with Nasdaq Listing Rule 5250(c)(1), resolving a previous noncompliance issue stemming from a delayed...

Continue Reading